Form 4: Guardant Health Director Acquires Shares Through RSU Vesting

Guardant Health, Inc. Director Meghan V. Joyce acquired 66 shares of common stock on July 4, 2025, through the vesting of Restricted Stock Units.

Summary

• Meghan V. Joyce, a Director at Guardant Health, Inc. (GH), acquired 66 shares of common stock on July 4, 2025, through the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Ms. Joyce directly beneficially owns 11,216 shares of common stock.
• The transaction involved the conversion of 66 derivative securities (RSUs) into common stock at an exercise price of $0.
• After this conversion, Ms. Joyce holds 67 remaining derivative securities (RSUs).
• The RSUs initially vested 25% on August 4, 2022, with the remaining 75% vesting in substantially equal monthly installments over a three-year period from August 4, 2022.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as it reflects a routine vesting of equity compensation for a director, indicating continued alignment of interests with shareholders through increased direct ownership.

Positives

• The vesting of 66 Restricted Stock Units (RSUs) into common stock represents a routine compensation event for Director Meghan V. Joyce, increasing her direct ownership in Guardant Health, Inc.

Future Outlook

The document, an SEC Form 4, reports an insider transaction and does not provide any forward-looking statements or guidance regarding Guardant Health, Inc.'s future performance or strategic outlook.

Industry Context

This SEC Form 4 filing details a routine insider transaction, specifically the vesting of Restricted Stock Units for a director. Such filings are standard disclosures for publicly traded companies and do not typically provide insights into broader industry trends or competitive landscapes, focusing instead on individual ownership changes.

Stakeholder Impact

• Shareholders: Increased alignment of interests between Director Meghan V. Joyce and shareholders due to her increased direct ownership in the company.

Next Steps

• Continued vesting of the remaining 67 Restricted Stock Units (RSUs) in substantially equal monthly installments until the three-year period from August 4, 2022, is complete.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, insider transaction, stock vesting, Restricted Stock Units, RSU, director compensation